Advertisement

Considerations in the Difficult-to-Manage Urea Cycle Disorder Patient

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Critical Care Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bachmann C.
        Outcome and survival of 88 patients with urea cycle disorders: a retrospective evaluation.
        Eur J Pediatr. 2003; 162: 410-416
        • Maestri N.E.
        • Clissold D.
        • Brusilow S.W.
        Neonatal onset ornithine transcarbamylase deficiency: a retrospective analysis.
        J Pediatr. 1999; 134: 268-272
        • Uchino T.
        • Endo F.
        • Matsuda I.
        Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan.
        J Inherit Metab Dis. 1998; 21: 151-159
        • Scaglia F.
        • Zheng Q.
        • O'Brien W.E.
        • et al.
        An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency.
        Pediatrics. 2002; 109: 150-152
        • Lee B.
        • Yu H.
        • Jahoor F.
        • et al.
        In vivo urea cycle flux distinguishes and correlates with phenotypic severity in disorders of the urea cycle.
        Proc Natl Acad Sci USA. 2000; 97: 8021-8026
        • Wilcken B.
        Problems in the management of urea cycle disorders.
        Mol Genet Metab. 2004; 81: S86-S91
        • Summar M.
        • Tuchman M.
        Proceedings of a consensus conference for the management of patients with urea cycle disorders.
        J Pediatr. 2001; 138: S6-S10
        • Steiner R.D.
        • Cederbaum S.D.
        Laboratory evaluation of urea cycle disorders.
        J Pediatr. 2001; 138: S21-S29
        • Reeds P.J.
        • Garlick P.J.
        Protein and amino acid requirements and the composition of complementary foods.
        J Nutr. 2003; 133: 2953S-2961S
        • Gidden F.
        • Shenkin A.
        Laboratory support of the clinical nutrition service.
        Clin Chem Lab Med. 2000; 38: 693-714
        • Bachmann C.
        Mechanisms of hyperammonemia.
        Clin Chem Lab Med. 2002; 40: 653-662
        • Butterworth R.F.
        Glutamate transporter and receptor function in disorders of ammonia metabolism.
        Ment Retard Dev Disabil Res Rev. 2001; 7: 276-279
        • Choi C.G.
        • Yoo H.W.
        Localized proton MR spectroscopy in infants with urea cycle defect.
        AJNR Am J Neuroradiol. 2001; 22: 834-837
        • Cederbaum S.D.
        • Yu H.
        • Grody W.W.
        • et al.
        Arginases I and II: do their functions overlap?.
        Mol Genet Metab. 2004; 81: S38-S44
        • Scaglia F.
        • Brunetti-Pierri N.
        • Kleppe S.
        • et al.
        Clinical consequences of urea cycle enzyme deficiencies and potential links to arginine and nitric oxide metabolism.
        J Nutr. 2004; 134: S2775-S2797
        • Zimmermann A.
        • Bachmann C.
        • Baumgartner R.
        Severe liver fibrosis in argininosuccinic aciduria.
        Arch Pathol Lab Med. 1986; 110: 136-140
        • Scaglia F.
        • Marini J.
        • Rosenberger J.
        • et al.
        Differential utilization of systemic and enteral ammonia for urea synthesis in control subjects and ornithine transcarbamylase deficiency carriers.
        Am J Clin Nutr. 2003; 78: 749-755
        • Shimomura Y.
        • Murakami T.
        • Nakai N.
        • et al.
        Exercise promotes BCAA catabolism: effects of BCAA supplementation on skeletal muscle during exercise.
        J Nutr. 2004; 134: 1583S-1587S
        • Obled C.
        • Papet I.
        • Breuille D.
        Metabolic bases of amino acid requirements in acute diseases.
        Curr Opin Clin Nutr Metab Care. 2002; 5: 189-197
        • Scaglia F.
        • Carter S.
        • O'Brien W.E.
        • et al.
        Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
        Mol Genet Metab. 2004; 81: S79-S85
        • Wolfe R.R.
        Regulation of skeletal muscle protein metabolism in catabolic states.
        Curr Opin Clin Nutr Metab Care. 2005; 8: 61-65
        • Caldovic L.
        • Morizono H.
        • Daikhin Y.
        • et al.
        Restoration of ureagenesis in N-acetylglutamate synthase deficiency by N-carbamylglutamate.
        J Pediatr. 2004; 145: 552-554
        • Leonard J.V.
        The nutritional management of urea cycle disorders.
        J Pediatr. 2001; 138: S40-S45
        • Kasumov T.
        • Brunengraber L.L.
        • Comte B.
        • et al.
        New secondary metabolites of phenylbutyrate in humans and rats.
        Drug Metab Dispos. 2004; 32: 10-19
        • Iafolla A.K.
        • Gale D.S.
        • Roe C.R.
        Citrate therapy in argininosuccinate lyase deficiency.
        J Pediatr. 1990; 117: 102-105
        • Renner C.
        • Sewell A.C.
        • Bervoets K.
        • et al.
        Sodium citrate supplementation in inborn argininosuccinate lyase deficiency: a study in a 5-year-old patient under total parenteral nutrition.
        Eur J Pediatr. 1995; 154: 909-914
        • Wagenmakers A.J.
        Protein and amino acid metabolism in human muscle.
        Adv Exp Med Biol. 1998; 441: 307-319
        • Buse M.G.
        • Reid S.S.
        Leucine. A possible regulator of protein turnover in muscle.
        J Clin Invest. 1975; 56: 1250-1261
        • Lynch C.J.
        • Halle B.
        • Fujii H.
        • et al.
        Potential role of leucine metabolism in the leucine-signaling pathway involving mTOR.
        Am J Physiol Endocrinol Metab. 2003; 285: E854-E863
        • Burlina A.B.
        • Ferrari V.
        • Dionisi-Vici C.
        • et al.
        Allopurinol challenge test in children.
        J Inherit Metab Dis. 1992; 15: 707-712